NCT02745678View on ClinicalTrials.gov

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Colitis, Ulcerative
Interventions
DRUG

Thermosensitive gel rectal formulation

Trial Locations (1)

94204

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT02745678 - Localized Therapeutics for the Treatment of Gastrointestinal Disorders II | Biotech Hunter | Biotech Hunter